BWM
GWPH

Baystate Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Baystate Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-40
Closed -$5K – 771
2020
Q2 		$5K Buy
+40
New +$4.54K ﹤0.01% 474

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Baystate Wealth Management's GWPH Position: Q3 2020 in Review

Baystate Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 40 shares — an estimated $5K sold.

Baystate Wealth Management first reported a position in GWPH in Q2 2020 and held it in 1 quarter. The position peaked at $5K in Q2 2020. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

  • Baystate Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Baystate Wealth Management sold 40 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $5K.
  • Baystate Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2020 and held it in 1 quarter.
  • Baystate Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5K in Q2 2020.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Baystate Wealth Management's 13F filing for Q3 2020, filed 14 Oct 2020.